Fundz

Iterative Scopes Announces $150 Million Series B To Advance Ai-Driven Precision Medicine For Gastroenterology

PRIVATEJan 19, 2022

Amount Raised

$150 Million

Round Type

Series B

CambridgeBiotechnologySoftwareHealth Care

Description

Iterative Scopes, a pioneer in the development of precision-based gastrointestinal (GI) disease technologies and software, announced today that it has raised $150 million in Series B financing to accelerate development of its core algorithmic innovations that are designed to transform gastroenterology care for patients. The round was co-led by Insight Partners and Clearlake Capital Group, L.P. (together with certain of its affiliates, “Clearlake”), as well as by returning investors Obvious Ventures, Johnson and Johnson Innovation-JJDC Inc., Eli Lilly, Breyer Capital and other industry and financial leaders.

Quick answer

ITERATIVE SCOPES, INC. raised $150 Million in a Series B round, dated January 19, 2022. ITERATIVE SCOPES, INC. is based in Cambridge, Maryland, United States.

How much did ITERATIVE SCOPES, INC. raise?
ITERATIVE SCOPES, INC. raised $150 Million in a Series B round on January 19, 2022.
What does ITERATIVE SCOPES, INC. do?
Iterative Scopes is fast becoming the leader in computational gastroenterology through its pioneering application of powerful, proprietary artificial intelligence tools to the practice of gastroenterology and drug..
Where is ITERATIVE SCOPES, INC. based and how big is it?
ITERATIVE SCOPES, INC. is based in Cambridge, Maryland, United States.

Source: Fundz verified event record.

Who to call at ITERATIVE SCOPES, INC., and when

A new round usually means ITERATIVE SCOPES, INC. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ITERATIVE SCOPES, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ITERATIVE SCOPES, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ITERATIVE SCOPES, INC.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ITERATIVE SCOPES, INC.

Location

14 Arrow Street

Cambridge, Maryland, United States

About

Iterative Scopes is fast becoming the leader in computational gastroenterology through its pioneering application of powerful, proprietary artificial intelligence tools to the practice of gastroenterology and drug development. It is taking a multi-tiered approach to tackling the challenges of endoscopic-driven disease management. The initial products and services offered by Iterative Scopes aim to identify and standardize relevant insights from endoscopic videos used for detection and monitoring of colorectal cancers and inflammatory bowel disease (IBD). Longer term, the company is building predictive models that can augment clinical trial endpoints and individualized therapeutic selection processes, with the potential to create novel endpoints that are better predictors of therapeutic response and disease outcomes. Spun out of MIT in 2017, the team is based in Cambridge, Massachusetts. For more information, visit www.iterativescopes.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ITERATIVE SCOPES, INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ITERATIVE SCOPES, INC.'s next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

ITERATIVE SCOPES, INC. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.